This research identifies a #immunotherapeutic strategy utilizing agonistic #CD40 to overcome pancreatic cancer's inherent treatment resistance. It achieves this by reprogramming suppressive regulatory T cells (Tregs) within the tumor microenvironment into active supporters of tumor-killing immune cells.
#Oncology #Immunology #CellBiology #sflorg
https://www.sflorg.com/2026/04/ongy04102602.html
#Oncology #Immunology #CellBiology #sflorg
https://www.sflorg.com/2026/04/ongy04102602.html
